Cargando…
Advance in microRNA as a potential biomarker for early detection of pancreatic cancer
Pancreatic cancer is characterized as a disease with low survival and high mortality because of no effective diagnostic and therapeutic strategies available in clinic. Conventional clinical diagnostic methods including serum markers and radiological imaging (CT, MRI, EUS, etc.) often fail to detect...
Autores principales: | Huang, Jing, Liu, Jianzhou, Chen-Xiao, Kevin, Zhang, Xuemei, Lee, W. N. Paul, Go, Vay Liang W., Xiao, Gary Guishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075408/ https://www.ncbi.nlm.nih.gov/pubmed/27795830 http://dx.doi.org/10.1186/s40364-016-0074-3 |
Ejemplares similares
-
Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers
por: Kenner, Barbara J., et al.
Publicado: (2017) -
Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells
por: Wang, Jiarui, et al.
Publicado: (2013) -
Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
por: Kenner, Barbara J., et al.
Publicado: (2015) -
Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008) -
Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer
por: Wu, Lun, et al.
Publicado: (2020)